FDA NDC Directory · JSON-LD · Markdown

MYDAYIS

NDC 54092-474 · HUMAN PRESCRIPTION DRUG · CAPSULE, EXTENDED RELEASE

Generic nameDEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, and AMPHETAMINE SULFATE
Labeler / ManufacturerTakeda Pharmaceuticals America, Inc.
Marketing categoryNew Drug Application (innovator) · App NDA022063
Dosage form / routeCAPSULE, EXTENDED RELEASE · ORAL
Active ingredientsAMPHETAMINE ASPARTATE MONOHYDRATE (9.375 mg/1)
AMPHETAMINE SULFATE (9.375 mg/1)
DEXTROAMPHETAMINE SACCHARATE (9.375 mg/1)
DEXTROAMPHETAMINE SULFATE (9.375 mg/1)
Marketing started20170620
Package count1

External sources

Source: openFDA. Public-domain (CC0).